ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

The pharmaceutical industry and natural products: historical status and new trends

David, Bruno; Wolfender, Jean-Luc*; Dias, Daniel A.
PHYTOCHEMISTRY REVIEWS2015-4DOI: 10.1007/s11101-014-9367-z
337被引1阅读
引用收藏
分享

摘要

Owing to the high diversity of terrestrial and marine organisms, natural products (secondary metabolites) are some of the most successful source of drug leads for the treatment of many diseases and illnesses. In the 1990s, advancements in automation [high-throughput screening (HTS)] and isolation technologies resulted in the surge in research towards natural products both in the fields of human health and agriculture. These strategies and techniques generated a substantial shift towards this 'green Eldorado', a real 'Green Rush' between 1990 and 2000. However, in the early 2000s most of the big Pharmas terminated their HTS and bioprospecting endeavours but to date, the low productivity of combichem and rational drug design is silently positioning pharmacognosy back on the rails and natural product discovery is remerging as a reputable source of current drugs on the market. Meanwhile, the World Health Organization has come to the realisation of the importance of biodiversity which would be able to offer affordable, therapeutic solutions to the majority of the world population. The preservation of the world's biodiversity and its access is a critical issue which could hamper a serene utilisation of natural products in the developing world with herbal-based phytopharmaceuticals representing a significant share of the total world pharmaceutical market. This review presents an industrial perspective discussing natural product drug discovery, lead research, botanicals, pro-drugs, synergy effects, drugs interactions with botanicals, traditional medicines, reverse pharmacognosy and presents the difficulties in accessing biodiversity.

学科与关键词

关键词
Drug discoveryHigh-throughput screening (HTS)BiodiversityPharmaceutical industryAccess and benefit sharing
相关
加载中…
  • The Ethnopharmacologic Contribution to Bioprospecting Natural Products
    Buenz, Eric J.*; Verpoorte, Rob; Bauer, Brent A.ANNUAL REVIEWS,4139 EL CAMINO WAY, PO BOX 10139, PALO ALTO, CA 94303-0897 USA, 2018.被引 51
  • 21st Century natural product research and drug development and traditional medicines
    Ngo, Linh T.; Okogun, Joseph I.; Folk, William R.*Natural Product Reports, 2013, 30(4): 584-592.被引 166
  • Rediscovery of natural compounds acting via multitarget recognition and noncanonical pharmacodynamical actions
    Bizzarri, Mariano*; Giuliani, Alessandro; Monti, Noemi; Verna, Roberto; Pensotti, Andrea; Cucina, AlessandraDrug Discovery Today, 2020, 25(5): 920-927.被引 11
查看全部 →

发表信息

论文状态
公开发表
期刊
PHYTOCHEMISTRY REVIEWS
发表日期
2015-04
卷期
第 14 卷, 第 2 期
页码
299-315
DOI
10.1007/s11101-014-9367-z
语言
ENGLISH
期刊收录
SCIE
期刊等级
Q2
成果收录
SCIE

作者

  • D

    David, Bruno (第一作者)

  • W

    Wolfender, Jean-Luc (通讯)

查看全部 3 位作者收起作者
  • D

    Dias, Daniel A.

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417